Imaging Epilepsy: Past, Passing, and to Come.
Authors
Affiliations (4)
Affiliations (4)
- National Institutes of Health, Bethesda, MD, USA.
- Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, UK.
- Harvard Medical School, Boston, MA, USA.
- Department of Radiation Medicine and Applied Sciences & Psychiatry, University of California, San Diego, CA, USA.
Abstract
New imaging techniques appearing over the last few decades have replaced procedures that were uncomfortable, of low specificity, and prone to adverse events. While computed tomography remains useful for imaging patients with seizures in acute settings, structural magnetic resonance imaging (MRI) has become the most important imaging modality for epilepsy evaluation, with adjunctive functional imaging also increasingly well established in presurgical evaluation, including positron emission tomography (PET), single photon ictal-interictal subtraction computed tomography co-registered to MRI and functional MRI for preoperative cognitive mapping. Neuroimaging in inherited metabolic epilepsies is integral to diagnosis, monitoring, and assessment of treatment response. Neurotransmitter receptor PET and magnetic resonance spectroscopy can help delineate the pathophysiology of these disorders. Machine learning and artificial intelligence analyses based on large MRI datasets composed of healthy volunteers and people with epilepsy have been initiated to detect lesions that are not found visually, particularly focal cortical dysplasia. These methods, not yet approved for patient care, depend on careful clinical correlation and training sets that fully sample broad populations.